What Are the Key Trends and EU Regulatory Considerations for Intimate Hygiene Products?
Intimate hygiene products are evolving beyond cleansing towards odour control, hydration and anti-ageing benefits. Their ingredients, claims and intended purpose determine their regulatory classification, making early assessment and robust claim substantiation essential.
The intimate hygiene market is evolving beyond its traditional focus on cleansing and freshness. Consumers are increasingly looking for products that do more than simply clean the intimate area. They want solutions that address odour, comfort, skin appearance, dryness, sensitivity and the visible effects of ageing.
This evolution is particularly interesting from a regulatory perspective. Intimate hygiene products can fall under different regulatory frameworks depending on their composition, intended purpose, mode of action and claims.
As a result, developing an intimate product is not simply a matter of selecting suitable ingredients and designing an attractive label. The regulatory classification must be established from the very beginning of the development process.
How Is the Intimate Hygiene Market Evolving Beyond Traditional Cleansing Products?
Traditional intimate hygiene products have generally focused on cleansing, freshness and respect for the physiological characteristics of the intimate area.
Mild surfactant systems, acidic pH, moisturising ingredients and botanical extracts have therefore become common features of intimate cleansers. However, the intimate hygiene market is expanding beyond these traditional functions, with consumers increasingly seeking products that address more specific needs.
One important area is odour management, with products designed to provide a feeling of freshness, reduce unpleasant odours or help maintain a pleasant smell over time.
Another emerging area is intimate anti-ageing, driven by the broader growth of the anti-ageing category in skincare and increasing consumer interest in the appearance and comfort of intimate skin.
These developments are part of a wider movement in cosmetics: consumers increasingly expect personal-care products to provide targeted and multifunctional benefits rather than simply perform a basic cleansing function. However, the regulatory implications become more complex as claims become more specific.
Intimate Anti-Ageing: What Does It Actually Mean?
“Anti-ageing” is a well-established concept in facial and body cosmetics. In the intimate area, however, the expression requires greater care.
From a cosmetic perspective, a product may legitimately be developed to improve the appearance and condition of the external intimate skin, provided that its claims remain within the cosmetic purpose established by Regulation (EC) No 1223/2009.
Possible cosmetic objectives may include moisturisation, improvement of skin smoothness, maintenance of elasticity or reduction of the appearance of dryness and roughness. The critical distinction is between a cosmetic claim concerning the appearance or condition of the skin and a claim suggesting a physiological, therapeutic or medical effect.
For example, a claim such as “helps improve the appearance of dry and less elastic intimate skin” is conceptually different from claiming that a product “restores vaginal tissue”, “treats vaginal atrophy” or “reverses hormonal ageing”.
The latter types of claims may move the product outside the conventional cosmetic framework and potentially into medicinal product or medical device territory, depending on the specific wording, intended purpose and mode of action.
This is why the concept of intimate anti-ageing should be translated into precise, substantiated cosmetic benefits rather than treated as a regulatory category in itself.
Why Is the Anatomical Area Important When Developing Intimate Hygiene Products?

The intimate area deserves particular consideration when formulating cosmetics. The external genital area is skin, but it is also a highly sensitive anatomical region. Formulators therefore need to consider factors such as surfactant mildness, fragrance exposure, preservative systems, pH, potential irritation and sensitisation.
A product intended for external intimate hygiene should not automatically be considered equivalent to an ordinary body cleanser simply because both are rinse-off products.
The safety assessment required under the EU Cosmetics Regulation must consider the intended and reasonably foreseeable use of the finished product. This includes the specific site of application and the characteristics of the target population.
The distinction between external use and application to mucosal or internal areas is particularly important. Marketing language should therefore clearly define where and how the product is intended to be used.
What Are the Regulatory Challenges of Odour Control Claims in Intimate Hygiene Products?
Odour-related claims are becoming increasingly important, but they also present one of the greatest regulatory challenges for intimate hygiene products.
There is a significant difference between:
- providing a pleasant fragrance;
- masking an unpleasant odour;
- reducing or neutralising odour;
- preventing the formation of odour;
- treating the underlying cause of an abnormal odour.
The first two concepts can generally fit comfortably within cosmetic positioning, provided that the claims are truthful and substantiated. The situation becomes more complicated when a product claims to prevent or eliminate odour by acting on microorganisms.
A statement such as “fresh fragrance for a long-lasting feeling of freshness” has a very different regulatory meaning from “eliminates the bacteria responsible for intimate odour”.
The latter may suggest an antimicrobial or biocidal function and therefore requires careful assessment under the Biocidal Products Regulation (EU) No 528/2012, in addition to considering the cosmetic framework.
In practice, the claim can be as important as the formulation itself in determining the regulatory pathway.
What Is the Difference Between Cosmetic and Biocidal Products for Intimate Hygiene?
This is particularly relevant for intimate hygiene products marketed with terms such as “antibacterial”, “antimicrobial” or “protective against bacteria”.
Under EU legislation, the intended purpose and principal mode of action are key elements in determining whether a product is a cosmetic product or a biocidal product.
A cosmetic cleanser can contain ingredients that have antimicrobial properties without necessarily becoming a biocide. However, if the product is presented as acting against microorganisms for a biocidal purpose, the regulatory assessment can change substantially.
This is why formulations should not be classified solely by looking at their ingredient lists. The claims, labelling, advertising and intended use must all be evaluated together.
For companies developing intimate hygiene products, this is particularly important because “antibacterial” positioning can be commercially attractive but may create significant additional regulatory obligations.
How Does Fragrance Masking Affect Intimate Hygiene Product Claims and Compliance?

Odour masking represents a potentially simpler cosmetic strategy.
A formulation can be designed to provide a pleasant sensory experience through fragrance, while the marketing communication focuses on freshness and confidence rather than on treating or eliminating an underlying condition. However, fragrance itself is not without regulatory considerations.
Under the EU Cosmetics Regulation, fragrance ingredients must comply with the applicable requirements for fragrance allergens and other restricted substances.
The evolving EU rules on fragrance allergen labelling are particularly relevant for intimate products, where consumers may be more sensitive to irritation and sensitisation concerns.
Formulators should therefore consider not only whether a fragrance provides the desired sensory profile, but also its allergen profile, concentration, regulatory status and suitability for the intended application area.
What Ingredients Are Used in Intimate Hygiene and Anti-Ageing Cosmetic Products?
The ingredient strategies used in modern intimate hygiene products increasingly resemble those found in facial skincare.
Humectants such as glycerin and glycols can support moisturisation. Emollients can improve skin feel, while ingredients such as panthenol, allantoin and selected botanical extracts may be used to support a soothing or conditioning positioning, provided that the corresponding claims can be substantiated.
Anti-ageing products may also incorporate ingredients associated with skin appearance, hydration and elasticity.
Nevertheless, the presence of a fashionable active ingredient does not automatically justify a claim. The principle established by Article 20 of Regulation (EC) No 1223/2009 is particularly important: cosmetic claims must not imply characteristics or functions that the product does not have.
The European Commission’s common criteria for cosmetic claims, including legal compliance, truthfulness, evidential support, honesty, fairness and informed decision-making, provide the framework for evaluating marketing statements.
Consequently, a formulation containing a recognised cosmetic active does not automatically support claims such as “anti-ageing”, “regenerating”, “restores collagen” or “rebalances intimate flora”. The claim must be supported by appropriate evidence.
What Evidence Is Needed To Substantiate Intimate Hygiene Cosmetic Claims?
As intimate products move from basic cleansing towards targeted benefits, claim substantiation becomes increasingly important.
For simple cleansing and moisturising claims, evidence may be generated through appropriate formulation data, ingredient documentation and finished-product testing, depending on the specific claim. For more ambitious claims, companies may need dedicated studies.
For example, a claim concerning long-lasting freshness may require appropriate sensory or instrumental testing. A claim concerning moisturisation may be supported through dermatological or instrumental studies.
If a company wishes to make a quantitative claim about odour reduction, a suitable methodology should be available to demonstrate that the claimed effect actually occurs.
This is particularly relevant because intimate products are often marketed using language that is emotionally powerful but scientifically vague: “confidence”, “freshness”, “protection”, “balance”, “wellness” and “youth”.
Although such language may be commercially effective, it should not obscure what the product actually does.
What Is the Difference Between Intimate Hygiene and Vaginal Health?
Another important distinction is between external intimate hygiene and vaginal health. The vagina has its own physiological environment and does not generally require conventional cleansing products internally. Consequently, products intended for internal vaginal application raise different safety and regulatory considerations compared with external intimate cleansers.
Claims referring to vaginal microbiota, pH restoration, infections, vaginal dryness associated with menopause or hormonal changes, or treatment of specific symptoms require particular attention.
A company should not assume that adding a probiotic, prebiotic, botanical extract, or lactic-acid-based system automatically permits claims concerning the vaginal microbiome or vaginal health. The scientific evidence, intended purpose and regulatory classification must therefore be assessed together.
When Should Regulatory Assessment Begin for Intimate Hygiene Products?

For companies entering this market, one of the most important lessons is that regulatory assessment should not be left until the final label is prepared. Instead, the development process should begin with a product concept and intended purpose, followed by a preliminary classification assessment. The formulation can then be developed consistently with that positioning.
For an EU cosmetic product, the regulatory process will ultimately include the Product Information File (PIF), Cosmetic Product Safety Report (CPSR), responsible person, notification through the Cosmetic Products Notification Portal (CPNP), compliant labelling and appropriate claim substantiation.
The manufacturing process should also comply with applicable good manufacturing practice principles, with ISO 22716 providing the recognised framework for cosmetic GMP.
If the product instead falls within the biocidal framework, substantially different requirements may apply, including active-substance status, product-type considerations, authorisation and specific claims and labelling requirements. This distinction can have a major impact on development costs and time-to-market.
Conclusion: The Future of Intimate Hygiene and Cosmetic Innovation
The evolution of intimate hygiene products reflects a broader transformation of the personal-care market. Consumers are no longer necessarily looking for a simple cleanser. They may want hydration, comfort, freshness, odour management, skin conditioning and solutions addressing the visible signs associated with ageing.
This creates opportunities for formulators and brands, but also increases regulatory complexity. The most successful products are likely to be those where formulation, claims, safety assessment and regulatory classification are developed together.
For intimate anti-ageing products in particular, the opportunity is not necessarily to reproduce facial anti-ageing technology literally, but to adapt the principles of modern skincare to the specific characteristics and expectations associated with intimate skin.
Similarly, for odour-control products, the distinction between masking an odour, neutralising it and biologically controlling its source should be clearly understood before making a claim.
Ultimately, the future of intimate hygiene is likely to be characterised by more targeted products, more sophisticated formulations and more demanding consumers. For manufacturers and brands, however, innovation will need to be accompanied by robust scientific substantiation and careful regulatory strategy.
In this category, the boundary between cosmetics, biocides, medical devices and medicinal products can become particularly important — and identifying that boundary early can be just as important as developing the formulation itself.
Key Takeaways: Intimate Hygiene Products, Odour Control and Anti-Ageing Regulations
- Intimate hygiene products are evolving beyond cleansing towards hydration, skin conditioning, odour control and anti-ageing.
- External intimate products require specific formulation and safety considerations, particularly regarding sensitive skin and mucosal exposure.
- Fragrance masking, odour neutralisation and antimicrobial action have different regulatory implications.
- Vaginal health claims require particular care and should not imply treatment or physiological effects without appropriate regulatory assessment.
- Cosmetic claims must be truthful and supported by appropriate scientific evidence.
- Early regulatory classification is essential, as products may fall under cosmetics, biocides, medical devices or medicinal product regulations.